logo

Valeant Pharmaceuticals International (VRX)



Trade VRX now with
  Date
  Headline
7/17/2017 7:03:21 AM Valeant To Sell Its Obagi Medical Products Business For $190 Mln In Cash
7/13/2017 8:32:18 AM Valeant Announces Redemption Of Remaining $500 Mln Of Its Outstanding 6.75% Senior Notes Due 2018
7/13/2017 8:32:12 AM Valeant To Redeem The Remaining $500 Mln Of Its Outstanding 6.75% Senior Notes Due 2018
7/10/2017 7:02:33 AM Valeant Pharma Says Uses Dendreon Pharma Sale Proceeds To Pay Down $811 Mln Of Its Senior Secured Term Loans
7/6/2017 7:01:48 AM Valeant: Bausch + Lomb Introduces Bausch + Lomb AQUALOX Contact Lenses
6/29/2017 7:00:55 AM Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group
6/19/2017 7:04:22 AM Valeant Elects John Paulson To Serve As A Director
6/8/2017 7:03:35 AM Valeant To Sell Its INova Pharmaceuticals Business For $930 Mln In Cash
6/8/2017 7:03:08 AM Valeant To Sell INova Pharma To A Company Jointly Owned By Pacific Equity Partners And Carlyle Group For $930 Mln
5/17/2017 7:55:35 AM Valeant And Actavis Agree To Stay Litigation Relating To Drug Xifaxan
5/17/2017 7:08:58 AM Salix Agrees To Stay Outstanding Litigation, Extend 30-month Stay Regarding Actavis' ANDA For Xifaxan
5/11/2017 3:51:38 PM Valeant Up 7% After Positive Patent Litigation Developments On Xifaxan